The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Alcohol Withdrawal in the Surgical Patient: Prevention and Treatment
Abstract
Alcohol is the most abused drug worldwide [1]. In the United States, the apparent per capita consumption of ethanol from all alcoholic beverage types combined was 2.21 gallons pure ethanol in 1994 [2]. In 1996, 109 million Americans aged >or=to 12 yr had used alcohol in the last month (51% of the population). Approximately 32 million (15% of the population) engaged in binge drinking (five or more drinks on at least one occasion in the last month), and approximately 11 million (5% of the population) were heavy drinkers (drinking five or more drinks per occasion on five or more days in the past 30 days). Traditionally, women have drunk less than men, but the gap is narrowing, especially between young women and men [3]. There are 100,000 Americans killed by alcoholism annually, at a cost of $90-$116 billion each year [4]. The risk of being admitted to a hospital due to chronic alcohol misuse increases with the amount consumed daily [5]. Chronic alcohol misuse is more common in surgical patients (e.g., up to 43% in otorhinolaryngological departments) than in psychiatric (30%) or neurological (19%) patients [6]. Alcohol influences many organ systems and promotes carcinogenesis [1,7-10]. More than 50% of patients with carcinomas of the gastrointestinal tract are chronic alcoholics [8]. Almost half of all trauma beds are occupied by patients who were injured while under the influence of alcohol [11-14]. In addition to the life-threatening complications of alcohol withdrawal syndrome (AWS), the rate of morbidity and mortality due to infections, cardiopulmonary insufficiency, or bleeding disorders is 2 to 4 times greater in chronic alcoholics [10,13-18]. Natural History, Manifestations, and Clinical Presentation of AWS The most feared postoperative complication of AWS is the development of an unforeseen delirium tremens. This can develop in chronic alcoholics who are alcohol-dependent according to the Diagnostic and Statistical Manual of Mental Disorders [19] or the International Classification of Diseases [20] criteria. Alcohol dependence includes physical dependence, tolerance, and compulsive alcohol use that becomes the main-goal directed activity of the subject. At least half of the chronic alcoholics scheduled for surgery or after trauma are alcohol-dependent [14,15]. The development of AWS can change a normal postoperative course into a life-threatening situation in which the patient requires intensive care unit (ICU) treatment. In addition to patient risk, the treatment also becomes more complicated and expensive [14,15]. AWS consists of a range of signs and symptoms that typically develop in alcohol-dependent people 6-24 h of their last drink. It may occur unintentionally if abstinence is enforced by illness or injury or other causes [21]. The symptoms of AWS were first described by Plinius Major as early as in the first century BC "…. hinc… tremulae manus…. furiales somni et inquies nocturna" [22,23]. Autonomic hyperactivity appears within hours of the last drink and usually peaks within 24 to 48 h. The most common features are tremulousness, sweating, nausea, vomiting, anxiety, and agitation. Neuronal excitation, which may include epileptiform seizures (frequently grand mal) usually occur within 12-48 h of abstinence. After these prodromi, delirium tremens, which is characterized by auditory and visual hallucinations, confusion, and disorientation, clouding of consciousness, impaired attention, and pronounced autonomic hyperactivity, develops. If left untreated, death by respiratory and cardiovascular collapse may result [21]. Despite the well known symptoms, the prevention of AWS is not always successful, and the development of AWS is potentially life-threatening. The Pathophysiology of AWS Chronic alcohol exposure exerts numerous pharmacological effects by means of interactions with various neurotransmitters and neuromodulators [24]. During chronic ethanol administration, compensatory changes can result in an up-regulation of glutamatergic transmission (e.g., by N-methyl-D-aspartate [NMDA] or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) and a down-regulation of GABAergic functions, restoring equilibrium in the presence of ethanol but resulting in withdrawal hyperactivity in the absence of ethanol [25]. The most widely accepted mechanism of adaptation to chronic ethanol exposure is up-regulation of the cyclic adenosine 3[prime],5[prime]-monophosphate (cAMP) pathway [26]. Whereas acute ethanol exposure stimulates the cAMP pathway in many neurons in the brain, chronic exposure inhibits it, therefore leading to a compensatory up-regulation of the cAMP pathway in certain brain regions (locus coeruleus, nucleus accumbens, ventral tegmental area) [27,28]. Up-regulation of the cAMP pathway can represent a form of physiological dependence; on removal of the drug, the up-regulated cAMP pathway can "overshoot" and contribute to features of withdrawal [27-30]. Up-regulation of the cAMP pathway interfere
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detecting Alcoholism: The CAGE Questionnaire
Ewing, J. A. (1984) · JAMA · doi:10.1001/jama.1984.03350140051025 · Cited by 3,005 · cited 1×
“In clinical routine, the CAGE ( 43 ) is a short, precise, and feasible 4-item questionnaire (Table 2). Patients with a CAGE score .2 are considered chronic alcoholics.”
BackgroundSULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Rewarding Actions of Phencyclidine and Related Drugs in Nucleus Accumbens Shell and Frontal Cortex
Carlezon, & Wise, R. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-09-03112.1996 · Cited by 327
Cited by
Jacobi, J., Fraser, G. L., Coursin, D. B., Riker, R. R., Fontaine, D., Wittbrodt, E. T., Chalfin, D. B., Masica, M. F., Bjerke, H. S., Coplin, W. M., et al. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00020 · Cited by 1,895
DAS-Taskforce, Baron, R., Binder, A., Biniek, R., Braune, S. A., Buerkle, H., Dall, P., Demirakca, S., Eckardt, R., Eggers, V., et al. (2015) · Europe PMC (PubMed Central) · doi:10.3205/000223 · Cited by 319
Self-citationUse of biomarkers for alcohol use disorders in clinical practice
Neumann, T., & Spies, C. (2003) · Addiction · doi:10.1046/j.1359-6357.2003.00587.x · Cited by 120
Self-citationWoods, A. D., Giometti, R., & Weeks, S. M. (2015) · JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2015-1602 · Cited by 23
Faustmann, T. J., Paschali, M., Kojda, G., Schilbach, L., & Kamp, D. (2025) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2029-6387 · Cited by 4
Metadata
- Authors
- Spies, C. D., & Rommelspacher, H.
- Venue
- Anesthesia & Analgesia
- Published
- 1999-04
- Volume
- 88
- Issue
- 4
- Pages
- 946-954
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2071258193
- Cited by
- 180
- References
- 5
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alcohol Withdrawal in the Surgical Patient: Prevention and Treatment. https://app.cochat.ai/papers/10.1097/00000539-199904000-00050
- The paper
- Spies, C. D., & Rommelspacher, H. (1999). Alcohol Withdrawal in the Surgical Patient: Prevention and Treatment. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-199904000-00050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.